C9orf72 and amyotrophic lateral sclerosis: While several of these biomarkers have been identified in certain patient populations such as ALS with C9orf72 mutations, the specificity of these biomarkers needs to be investigated to see if these markers will be useful in sporadic ALS or ALS with other mutations.